Phase III trial of a patented formulation of a Traditional Chinese Medicine in patients with coronary disorders

Trial Profile

Phase III trial of a patented formulation of a Traditional Chinese Medicine in patients with coronary disorders

Recruiting
Phase of Trial: Phase III

Latest Information Update: 15 May 2013

At a glance

  • Drugs Cardiovascular therapies (Primary) ; Traditional-Chinese-medicine (Primary)
  • Indications Coronary disorders
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 15 May 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013, as reported in a China Pharma Holdings media release.
    • 16 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top